<?xml version="1.0" encoding="UTF-8"?>
<p id="Par96">Additionally, oseltamivir (Tamiflu), which is approved for the treatment of influenza A and B, is used to target the neuraminidase distributed on the surface of the influenza virus to inhibit the spread throughout the body. Several clinical trials are studying the effectiveness of oseltamivir against COVD-19 and also in combinations with chloroquine and favipiravir. However, a study in Wuhan reported no positive outcomes after administering oseltamivir and it does not serve as a recommended treatment for COVID-19 [
 <xref ref-type="bibr" rid="CR88">88</xref>].
</p>
